[Tokyo, Japan/London, UK] Sosei Co. Ltd., a public Japanese biopharmaceutical company, announced today the revisions to its consolidated financial forecasts for the Fiscal Year ending March 2006, updating from the forecasts announced on 19 July 2005.
1. Revised Financial Forecast for the Fiscal Year 2005 (1 April 2005 – 31 March 2006)
[Consolidated] (JY: Million)
Sales Ordinary Profit/(Loss) Net Income/(Loss)
Original Forecast (A) 100-2,600 (5,700)-(3,600) (5,700)-(3,600)
Revised Forecast (B) 100-2,600 (5,000)-(2,900) (5,000)-(2,900)
Increase (Decrease) (B-A) 0 700 700
Increase (Decrease) % 0 12.3-19.4 12.3-19.4
Note:The non-consolidated Financial Forecast for the Fiscal Year 2005 is unrevised.
2. Reasons for Revision